| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.41▼ | 2.41▼ | 2.42▼ | 2.44▼ | 1.99▲ |
| MA10 | 2.43▼ | 2.42▼ | 2.40▼ | 2.36▼ | 1.85▲ |
| MA20 | 2.40▼ | 2.41▼ | 2.42▼ | 1.97▲ | 2.00▲ |
| MA50 | 2.42▼ | 2.44▼ | 2.37▼ | 1.85▲ | 1.45▲ |
| MA100 | 2.40▼ | 2.22▲ | 1.98▲ | 2.01▲ | 1.07▲ |
| MA200 | 2.05▲ | 1.92▲ | 1.87▲ | 1.62▲ | 1.47▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.002▼ | -0.011▼ | 0.055▲ | 0.004▲ |
| RSI | 44.278▼ | 45.408▼ | 46.757▼ | 61.191▲ | 57.234▲ |
| STOCH | 24.861 | 52.993 | 63.098 | 82.935▲ | 52.923 |
| WILL %R | -77.500▼ | -57.407 | -52.439 | -17.483▲ | -20.270▲ |
| CCI | -112.620▼ | -55.343 | -42.584 | 54.695 | 124.076▲ |
|
Thursday, August 07, 2025 01:26 PM
IN8bio is developing a platform of cell therapies using gamma-delta T cells, a type of immune cell believed to help target and destroy cancer cells. Its current lead programs include INB-200 for ...
|
|
Tuesday, March 18, 2025 05:12 AM
IN8bio, Inc., a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies for cancer and autoimmune diseases, will participate in the Immuno-Oncology 360° Conference 2025 from ...
|
|
Thursday, March 13, 2025 01:30 PM
IN8BIO ($INAB) posted quarterly earnings results on Thursday, March 13th. The company reported earnings of -$0.04 per share, beating estimates of -$0.08 by $0.04. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/01/26 | 2.35 | 2.55 | 2.2219 | 2.35 | 189,294 |
| 08/01/26 | 2.50 | 2.501 | 2.15 | 2.40 | 247,378 |
| 07/01/26 | 2.48 | 2.60 | 2.39 | 2.50 | 105,599 |
| 06/01/26 | 2.475 | 2.60 | 2.33 | 2.47 | 112,455 |
| 05/01/26 | 2.53 | 2.53 | 2.39 | 2.47 | 90,642 |
| 02/01/26 | 2.32 | 2.59 | 2.25 | 2.46 | 258,729 |
| 31/12/25 | 2.31 | 2.3775 | 2.235 | 2.34 | 110,547 |
| 30/12/25 | 2.02 | 2.34 | 2.02 | 2.33 | 233,488 |
| 29/12/25 | 2.20 | 2.235 | 1.9301 | 2.01 | 242,779 |
| 26/12/25 | 1.92 | 2.24 | 1.8201 | 2.23 | 291,361 |
|
|
||||
|
|
||||
|
|